Mapping Silent Viral Threats Across Africa
In 2022, Uganda reported an alarming outbreak of Marburg virus disease (MARV). Two people in the southwest developed high fever, vomiting, and bleeding, which are classic signs of MARV, one ...
MIRNA is a collaborative research network working across nine countries in sub-Saharan Africa and South Asia to strengthen maternal immunisation programmes in readiness for the introduction of new life-saving vaccines which will improve foetal and infant health.
Maternal vaccines protect mothers and infants from life-threatening infectious diseases during the most vulnerable stages of life.
A cross-institutional, cross-country consortium representing key regions in Africa and Asia.
Learn about the work MIRNA have been doing to support maternal immunisation acceleration in LMICs
Subscribe to MIRNA's newsletter and follow updates to stay informed about the latest research and activities.
In 2022, Uganda reported an alarming outbreak of Marburg virus disease (MARV). Two people in the southwest developed high fever, vomiting, and bleeding, which are classic signs of MARV, one ...
Antimicrobial resistance (AMR) is a growing threat in Cambodia, where it is estimated that since 1990 approximately 3,000 lives have been lost each year as a result of drug-resistant infections. ...
Storytelling workshop For decades, leprosy has been associated not only with physical suffering but also with stigma, discrimination, and deep psychological scars [1]. In communities where the disease is still ...
Geneva, 25 July 2025 – The Board of Gavi, the Vaccine Alliance this week endorsed a series of adjustments to bring Gavi’s strategy for its next five-year period (2026-2030) in line with available resources while it continues to engage with ... Read more
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
SPEAC’s Special Populations team, in collaboration with Instituto de Efectividad Clínica y Sanitaria (IECS) and Tulane University, has launched an LSR and meta-analysis tool focused on the safety, effectiveness, and immunogenicity of Chikungunya vaccines Read more